Answers are grounded in this paper and cite their sources.
Case report reveals atypical bone lesions in acute promyelocytic leukemia, indicating diagnostic challenges for timely treatment.
Introduction/Objective Acute Promyelocytic Leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) that, if left untreated, carries a high mortality rate, often due to catastrophic bleeding or thrombotic complications arising from severe coagulopathy within days to weeks of symptom onset. Patients commonly present with fatigue, pallor, infections, and bleeding manifestations associated with coagulopathy. Prompt recognition and initiation of targeted therapy, particularly with all-trans retinoic acid (ATRA), have transformed APL from a highly fatal disease to one with a high cure rate, provided treatment is started without delay. Atypical presentations can obscure the diagnosis and delay life-saving interventions. We report a case of APL initially presenting with multiple bone lesions on imaging, a rare and misleading manifestation that mimicked metastatic malignancy and posed diagnostic challenges. Methods/Case Report A 72-year-old female with a history of WHO Grade 3 meningioma, post-resection and receiving radiotherapy, presented with a fall and ongoing lower back pain. MRI revealed compression fractures at T11 and L2, along with multiple lytic lesions, concerning for metastatic disease. CBC showed pancytopenia. She underwent image-guided vertebral augmentation and bone biopsy. H&E sections showed bone fragments and hypercellular marrow with sheets of left-shifted granulocytic precursors. Immunohistochemistry was positive for CD33, CD43, myeloperoxidase, and S100, and negative for CD34 and CD117. The differential diagnosis included reactive myeloid proliferation, myeloid neoplasm, or sampling bias, missing the metastatic lesion. A repeat bone biopsy yielded similar findings without a definitive diagnosis. Persistent cytopenias prompted a bone marrow biopsy. Wright Giemsa-stained aspirate smear showed numerous atypical myeloid precursors, some with prominent Auer rods. The core biopsy revealed hypercellular marrow with sheets of left-shifted granulocyte precursors. Flow cytometry identified an abnormal myeloid population lacking CD34 and expressing CD45, dim CD117, CD13, CD64, CD33, partial HLA-DR, and CD56. FISH demonstrated t(15;17) PML-RARA translocation in 92% of cells, consistent with acute promyelocytic leukemia (APL). Results NA Conclusion This case represents an unusual presentation of acute promyelocytic leukemia (APL), initially manifesting as a pathologic fracture with imaging findings concerning for metastatic disease. Immunohistochemical studies on the bone biopsy sections showed positivity for myeloid markers, including CD33 and CD43, along with unexpected expression of S100. A similar immunophenotype was observed in the bone marrow core. Although S100 is not a well-established marker in acute myeloid leukemia (AML), its expression in this case suggests a potentially underrecognized pattern in myeloid neoplasms. The initial bone biopsy posed diagnostic challenges due to the absence of cytologic preparation and the unusual clinical context. Early recognition of atypical presentations of APL is essential, as delays in diagnosis can lead to postponed initiation of life-saving therapy. This case underscores the importance of maintaining a broad differential when evaluating lytic bone lesions. Awareness of uncommon manifestations of APL can help prevent misdiagnosis and ensure timely initiation of therapy for this highly curable, yet potentially fatal, acute leukemia.
No takes yet. Share an insight, caveat, or question.
Choe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: